The objectives of this program are to train graduate students for a research career in academia, pharmaceutical companies, or government research agencies in the general area of pharmacology, with a focus on signal transduction, structural biology, neuropharmacology, and drug discovery. The program is designed to adapt to students'interest a will provide a strong biochemical, neuroscience, biophysical, and physiological background that will enable the student (1) to understand the molecular basis of currently used therapeutics;(2) to design experiments (a) to identify potential targets;and (b) t elucidate signal transduction mechanisms of new physiological agents or new therapeutics, (c) to solve macromolecular structures of interest in pharmacology, and (d) use modern tools for drug discovery. To achieve these ends, the pharmacology program at Yale was changed with new faculty and courses. Modern techniques in molecular pharmacology, cell and molecular biology, structural biology, chemistry, biochemistry, physiology and biophysics will be available to the trainee to achieve these goals. The trainee will have constant exposure to a variety of research programs of the faculty and over one hundred senior postdoctoral fellows who provide an additional resource for the trainees.

Public Health Relevance

The training program is designed to produce high-quality independent scientists with expertise in the general area of pharmacology and signal transduction.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Okita, Richard T
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Yale University
Schools of Medicine
New Haven
United States
Zip Code
Lee, Monica Y; Luciano, Amelia K; Ackah, Eric et al. (2014) Endothelial Akt1 mediates angiogenesis by phosphorylating multiple angiogenic substrates. Proc Natl Acad Sci U S A 111:12865-70
Park, Eon Joo; Grabi?ska, Kariona A; Guan, Ziqiang et al. (2014) Mutation of Nogo-B receptor, a subunit of cis-prenyltransferase, causes a congenital disorder of glycosylation. Cell Metab 20:448-57
Raina, Kanak; Noblin, Devin J; Serebrenik, Yevgeniy V et al. (2014) Targeted protein destabilization reveals an estrogen-mediated ER stress response. Nat Chem Biol 10:957-62
Swartz, Rebecca K; Rodriguez, Elisa C; King, Megan C (2014) A role for nuclear envelope-bridging complexes in homology-directed repair. Mol Biol Cell 25:2461-71
Guayasamin, Ryann C; Reynolds, Tracy D; Wei, Xin et al. (2014) Type III interferon attenuates a vesicular stomatitis virus-based vaccine vector. J Virol 88:10909-17
Pantouris, Georgios; Rajasekaran, Deepa; Garcia, Alvaro Baeza et al. (2014) Crystallographic and receptor binding characterization of Plasmodium falciparum macrophage migration inhibitory factor complexed to two potent inhibitors. J Med Chem 57:8652-6
Howard, Conor J; Hanson-Smith, Victor; Kennedy, Kristopher J et al. (2014) Ancestral resurrection reveals evolutionary mechanisms of kinase plasticity. Elife 3:
Zhang, Ye; Cobleigh, Melissa A; Lian, Jian-Qi et al. (2011) A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus. Gastroenterology 141:1897-906
Cobleigh, Melissa A; Buonocore, Linda; Uprichard, Susan L et al. (2010) A vesicular stomatitis virus-based hepatitis B virus vaccine vector provides protection against challenge in a single dose. J Virol 84:7513-22
Massimine, Kristen M; Doan, Lanxuan T; Atreya, Chloe A et al. (2005) Toxoplasma gondii is capable of exogenous folate transport. A likely expansion of the BT1 family of transmembrane proteins. Mol Biochem Parasitol 144:44-54

Showing the most recent 10 out of 16 publications